Cargando…

Renal toxicities associated with pembrolizumab

OBJECTIVE: Expanded clinical experience with patients treated by pembrolizumab has accumulated. However, renal toxicities associated with this anti-programmed cell death 1 agent are poorly described because kidney histology is rarely sought. As a nephrology referral centre, we aimed to describe the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Izzedine, Hassan, Mathian, Alexis, Champiat, Stephane, Picard, Cécile, Mateus, Christine, Routier, Emilie, Varga, Andrea, Malka, David, Leary, Alexandra, Michels, Judith, Michot, Jean-Marie, Marabelle, Aurélien, Lambotte, Olivier, Amoura, Zahir, Soria, Jean-Charles, Kaaki, Sihem, Quellard, Nathalie, Goujon, Jean-Michel, Brocheriou, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Drug-Induced Nephropathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366307/ https://www.ncbi.nlm.nih.gov/pubmed/30746132 http://dx.doi.org/10.1093/ckj/sfy100

Ejemplares similares

Pembrolizumab-related renal toxicities: diagnosis first, treatment later
por: Sprangers, Ben
Publicado: (2018)

Azathioprine hypersensitivity syndrome in anti-myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Greite, Robert, et al.
Publicado: (2018)

Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension
por: Hanna, Ramy M, et al.
Publicado: (2018)

Obesity as a Risk Factor for Radiographic Contrast-Induced Nephropathy
por: Kabeer, Muhammad Asif, et al.
Publicado: (2020)

Acute Tubular Injury and Renal Arterial Myocyte Vacuolization Following Crizotinib Administration
por: Izzedine, Hassan, et al.
Publicado: (2020)

Acalabrutinib in Membranous Nephropathy Associated With Chronic Lymphocytic Leukemia
por: Izzedine, Hassan, et al.
Publicado: (2022)

Oxalate nephropathy is a major cause of kidney injury in surgically treated pancreatic adenocarcinoma patients
por: Desbuissons, Geoffroy, et al.
Publicado: (2019)

Podocyturia: why it may have added value in rare diseases
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2018)

New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases
por: Mignani, Renzo, et al.
Publicado: (2018)

Will the FAbry STabilization indEX make its way to everyday clinical practice?
por: Cairns, Tereza, et al.
Publicado: (2018)

Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes
por: Trimarchi, Hernán, et al.
Publicado: (2018)

Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney disease
por: Edwards, Marie E, et al.
Publicado: (2018)

MYH9-related disorders display heterogeneous kidney involvement and outcome
por: Tabibzadeh, Nahid, et al.
Publicado: (2018)

MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy
por: Fernandez-Prado, Raul, et al.
Publicado: (2019)

A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy
por: Tziastoudi, Maria, et al.
Publicado: (2017)

Changes in metformin use in chronic kidney disease
por: Imam, Talha H.
Publicado: (2017)

A novel heterozygous mutation in the ATP6V0A4 gene encoding the V-ATPase a4 subunit in an adult patient with incomplete distal renal tubular acidosis
por: Imai, Eri, et al.
Publicado: (2016)

Familial vasculitides: granulomatosis with polyangitis and microscopic polyangitis in two brothers with differing anti-neutrophil cytoplasm antibody specificity
por: Prendecki, Maria, et al.
Publicado: (2016)

Anticancer Drug-Induced Capillary Leak Syndrome
por: Izzedine, Hassan, et al.
Publicado: (2022)

Clinical features and outcomes in a cohort of patients with immunoglobulin G4-related disease at a university hospital in Spain
por: Quero, Maria, et al.
Publicado: (2019)

Acute Tubular Necrosis and Interstitial Nephritis during Pemetrexed Therapy
por: Michels, Judith, et al.
Publicado: (2009)

Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types
por: Martin‐Romano, Patricia, et al.
Publicado: (2020)

Associations between sex and incident chronic kidney disease in a prospective diabetic cohort
por: Yu, Margaret K, et al.
Publicado: (2015)

Kidney dysfunction due to AA amyloidosis in a morbidly obese female
por: Izzedine, Hassan, et al.
Publicado: (2023)

Pathophysiological Changes in Rhesus Monkeys with Paraquat-Induced Pulmonary Fibrosis
por: Shao, Mingyang, et al.
Publicado: (2022)

Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers
por: Baldini, Capucine, et al.
Publicado: (2022)

Clarkson’s Disease Episode or Secondary Systemic Capillary Leak-Syndrome: That Is the Question!
por: Pineton de Chambrun, Marc, et al.
Publicado: (2021)

Traumatic Brain Injury: Patient Characteristics, Hospital Costs and Trends Over Time
por: Patel, Pankaj A., et al.
Publicado: (2014)

Edoxaban drug–drug interactions with ketoconazole, erythromycin, and cyclosporine
por: Parasrampuria, Dolly A., et al.
Publicado: (2016)

Evolution of Nutritional Status after Early Nutritional Management in COVID-19 Hospitalized Patients
por: Bedock, Dorothée, et al.
Publicado: (2021)

Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?
por: Martin-Romano, Patricia, et al.
Publicado: (2021)

Unlikely association of nephrectomy post-mRCC with anti-VEGF-induced renal TMA
por: Izzedine, Hassane, et al.
Publicado: (2011)

Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic
por: Bayle, Arnaud, et al.
Publicado: (2021)

Editor Profiles: Guest Editors of Special Column on Drug- and Chemical-Induced Liver Injury
Publicado: (2021)

Evaluation of Potential Drug‐Drug Interaction Risk of Pexidartinib With Substrates of Cytochrome P450 and P‐Glycoprotein
por: Zahir, Hamim, et al.
Publicado: (2020)

Anti-VEGF drugs in the prevention of blindness
por: Yorston, David
Publicado: (2014)

Anti-VEGF treatment for acute ROP – not yet recommended!
por: Gilbert, Clare
Publicado: (2014)

The Situation of Chemokine Ligands and Receptors Gene Expression, Following the Oral Administration of Drug Mannuronic Acid in Rheumatoid Arthritis Patients
por: Aslani, Mona, et al.
Publicado: (2020)

Chitinases: Therapeutic Scaffolds for Allergy and Inflammation
por: Madan, Kirtika, et al.
Publicado: (2020)

Onychomycosis: An Updated Review
por: Leung, Alexander K.C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kht8k2762ianikrpa2vn52no4p